Table 1 The six drugs tested.
From: The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
|  | Drug | Concentration (μg/ml or nM) |
|---|---|---|
Group 1 | COX-2 inhibitor – Etoricoxib | 4 μg/ml (1.1·10-5 M) |
Group 2 | Methotrexate | 1 μg/ml (2.2·10-6 M) |
Group 3 | Dexamethasone | 4 ng/ml |
|  | Etanercept (anti-TNF; rh soluble TNF-receptor) | 1 μg/ml |
|  | Infliximab (anti-TNF; chimeric monoclonal antibody) | 118 μg/ml |
|  | Leflunomide (pyrimidine synthesis inhibitor) | 4 μg/ml (1.5·10-5 M) |